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The innate immune system detects pathogen- and
host-derived double-stranded DNA exposed to the
cytosol and induces type I interferon (IFN) and other
cytokines. Here, we identified interferon-inducible
tripartite-motif (TRIM) 56 as a regulator of double-
stranded DNA-mediated type I interferon induction.
TRIM56 overexpression enhanced IFN-b promoter
activation after double-stranded DNA stimulation
whereas TRIM56 knockdown abrogated it. TRIM56
interacted with STING and targeted it for lysine
63-linked ubiquitination. This modification induced
STING dimerization, which was a prerequisite for
recruitment of the antiviral kinase TBK1 and subse-
quent induction of IFN-b. Taken together, these
results indicate that TRIM56 is an interferon-induc-
ible E3 ubiquitin ligase that modulates STING to con-
fer double-stranded DNA-mediated innate immune
responses.
INTRODUCTION
The innate immune system has evolved as the first line of host
defense against a variety of invading pathogens. The initiation
of innate immune responses relies on the recognition of path-
ogen components by germline-encoded pattern-recognition
receptors (PRRs), which include membrane-bound Toll-like
receptors (TLRs) and cytosolic RIG-I-like receptors (RLRs),
NOD-like receptors (NLRs; also known as nucleotide-binding
domain and leucine-rich repeat containing molecules), and
unidentified DNA sensors (Baccala et al., 2009; Medzhitov,
2007; Schroder and Tschopp, 2010; Takeuchi and Akira, 2010;
Yoneyama and Fujita, 2009). Upon recognition, they initiate
signal transduction pathways that lead to the induction of
type I interferon (IFN) and proinflammatory cytokines, which
are required for innate immune responses as well as for shaping
subsequent adaptive immune responses.IDNA derived from DNA viruses and bacteria as well as
damaged host cells or cells that have escaped from apoptosis
are triggers for innate immune responses (Hornung and Latz,
2010; Ishii and Akira, 2006; Nagata et al., 2010; Yanai et al.,
2009). Although TLR9 is known to recognize CpG DNA derived
from viruses and bacteria in the endolysosome, there is evidence
that double-stranded (ds) DNA delivered to the cytoplasm is
recognized by one or more cytosolic sensors (Ishii et al., 2006;
Stetson andMedzhitov, 2006; Yoshida et al., 2005). DNA-depen-
dent activator of IFN-regulatory factors (DAI) (also known as
ZBP1 or DLM-1) was identified as an intracellular dsDNA sensor
that binds to dsDNA and increases type I IFN induction (Takaoka
et al., 2007). However, a dispensable role of DAI in dsDNA-
elicited innate and adaptive immune responses in vivo was
revealed by a study on DAI-deficient mice (Ishii et al., 2008).
It was also suggested that AT-rich dsDNA serves as a template
for transcription to dsRNA by RNA polymerase III, which is
recognized by the RLR member RIG-I, suggesting that RIG-I
recognizes intermediates of dsDNA rather than dsDNA itself
(Ablasser et al., 2009; Chiu et al., 2009). IFN-inducible absent
in melanoma 2 (AIM2), which contains a pyrin and a HIN-200
DNA-binding domain, was identified to bind to dsDNA and
form an ASC-containing inflammasome, which triggers cas-
pase-1-dependent IL-1b production rather than type I IFN
(Bu¨rckstu¨mmer et al., 2009; Fernandes-Alnemri et al., 2009; Hor-
nung et al., 2009; Roberts et al., 2009). Collectively, these find-
ings suggest the existence of unknown cytosolic PRRs that
sense dsDNA and induce type I IFN production.
Stimulator of interferon genes (STING) (also known as MITA,
ERIS, or MPYS) was identified as a molecule that activates the
IFN-b promoter after overexpression and is a transmembrane
protein that resides in the ER and/or mitochondria (Ishikawa
and Barber, 2008; Jin et al., 2008; Sun et al., 2009; Zhong
et al., 2008). Cells derived from STING-deficient mice fail to
induce type I IFN production in response to dsDNA and infection
with herpes simplex virus 1 (HSV-1) and Listeria monocytogenes
(L. monocytogenes) that deliver DNA to the host cytosol. STING-
deficient mice are also susceptible to HSV-1 infection (Ishikawa
et al., 2009). In addition, STING-deficient mice show a remark-
able reduction in cytotoxic T cell responses after plasmid DNAmmunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc. 765
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TRIM56 Positively Regulates STING Functionvaccination (Ishikawa et al., 2009), indicating that STING is an
essential component of dsDNA-mediated immune responses
in vivo. Furthermore, STING-deficient cells display a consider-
able reduction in type I IFN production after infection with the
negative single-stranded RNA virus vesicular stomatitis virus
(VSV) that is recognized by RIG-I (Ishikawa and Barber, 2008).
STING interacts with IPS-1 (also known as MAVS, CARDIF, or
VISA), an essential adaptor for RLRs, at mitochondria (Ishikawa
and Barber, 2008; Zhong et al., 2008). Thus, in addition to
its pivotal role in the responses to cytosolic DNA, STING
plays a pivotal role in RIG-I-mediated antiviral innate immune
responses. In response to dsDNA stimulation, STING becomes
relocalized to punctate structures, where the kinase TBK1 is
recruited (Ishikawa and Barber, 2008; Saitoh et al., 2009; Zhong
et al., 2008). It is likely that this recruitment induces TBK1 activa-
tion that results in phosphorylation of the transcription factor
IRF3 and transcription of type I IFN genes during dsDNA-driven
signaling. However, it remains to be defined how STING activa-
tion is controlled.
In the present study, we performed a functional screening and
identified tripartite-motif (TRIM) 56. TRIM56 was induced by
type I IFN and its overexpression enhanced dsDNA-mediated
type I IFN induction. TRIM56 interacted with STING and pro-
moted STING ubiquitination, which was a prerequisite for
TBK1 recruitment and type I IFN induction.
RESULTS
Identification of TRIM56
To search for molecules involved in the innate immune
responses to cytosolic DNA, we carried out an expression
screening of a mouse carcinoma cDNA library. HEK293 cells
were transiently transfected with a plasmid derived from the
library along with an IFN-b promoter-luciferase reporter plasmid.
The cells were then stimulated with dsDNA [poly (dA:dT)-poly
(dT:dA)], herein referred to as poly (dA:dT), or dsRNA [poly
(I:C)] by transfection, followed by measurement of the luciferase
expression by a reporter assay. In a primary screening of around
1000 clones, we obtained one clone that displayed a marked
increase in luciferase expression compared with the control
plasmid-transfected cells (Figure 1A). This clone contained
an open reading frame for TRIM56, a member of the TRIM
family proteins (accession numbers BC045615, BG976873) (Fig-
ure 1B). Mouse TRIM56 contains an open reading frame of 2205
bases, encoding 734 amino acids. TRIM56 contains a RING
domain, B-box domain, and coiled-coil domain in the N-terminal
region (Figure 1B). The C-terminal region of TRIM56 did not
share considerable homology with the C-terminal regions of
other TRIMs. Expression of TRIM56 was upregulated after stim-
ulation with poly (I:C) and poly (dA:dT) as evaluated by RT-PCR
analysis (Figure 1C), consistent with a previous report showing
that TRIM56 is IFN inducible (Carthagena et al., 2009).
We constructed an expression plasmid encoding FLAG-
tagged TRIM56 to confirm its capability of increasing the IFN-b
promoter activity. Overexpression of FLAG-TRIM56 alone into
primary mouse embryonic fibroblast (MEF) cells resulted in
8-fold increases in the reporter gene expression (Figure 1D).
Furthermore, FLAG-TRIM56 overexpression enhanced poly
(dA:dT)- and poly (I:C)-stimulated IFN-b promoter activation766 Immunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc.(Figure 1D). Similarly, enhanced IFN-b promoter activation
by TRIM56 was also observed in HEK293 cells (Figure S1A
available online). Moreover, TRIM56 overexpression also
increased the IFN-b promoter activation induced by 5,6-dime-
thylxanthenone-4-acetic acid (DMXAA), an antitumor agent
that induces type I IFN via TBK1 and IRF3 (Figure S1B; Roberts
et al., 2007).
Next, we transduced a retroviral vector encoding TRIM56
into MEF cells to investigate whether TRIM56 regulates innate
immune responses to poly (dA:dT). We infected MEF cells
derived from TBK1-deficient mice with retrovirus encoding
TBK1 and found that TBK1 transduction restored poly (dA:dT)
stimulation-induced production of IP-10, an IFN-inducible che-
mokine (Figure 1E). Notably, cotransduction of TBK1 together
with TRIM56 markedly enhanced IP-10 production in response
to poly (dA:dT) stimulation (Figure 1E). These findings sug-
gested that TRIM56 positively regulates dsDNA-mediated
IFN-b induction.
TRIM56KnockdownAbrogates the Responses to dsDNA
and Poly (I:C)
To address the physiological function of TRIM56 in dsDNA-
induced responses, we employed a knockdown strategy involv-
ing two distinct siRNAs targeting the human TRIM56 gene
(Tr56-1 and Tr56-2). HEK293 cells treated with these siRNAs
displayed a considerable reduction in TRIM56 expression, as
confirmed by RT-PCR (Figure 2A, top) and immunoblot (Fig-
ure 2A, bottom) analyses. These siRNAs also decreased
TRIM56 expression in HeLa cells (data not shown). In TRIM56
knockdown cells, IFN-b and IFN-stimulation responsive ele-
ment (ISRE) promoter activation was significantly reduced after
poly (dA:dT) transfection (Figure 2B). IFN-b promoter activation
induced by poly (I:C) was also reduced by TRIM56 knockdown
(Figure 2C). Moreover, poly (dA:dT)-induced upregulation of
IFNB1 and CXCL10 was reduced in TRIM56-knockdown
HEK293 cells (Figure 2D). CXCL10mRNA induction after Listeria
monocytogenes infection was also reduced in TRIM56-knock-
down HeLa cells (Figure 2E). Furthermore, TRIM56 knockdown
in HEK293 cells resulted in impaired IRF3 nuclear translocation
by poly (dA:dT) (Figure 2F). These results strongly suggest that
TRIM56 is involved in poly (dA:dT) and poly (I:C)-induced type I
IFN production.
We next investigated whether TRIM56 is required for poly
(dA:dT)-mediated responses in normal human cells. We nucleo-
fected normal human lung fibroblasts with control siRNA or
siRNA for TRIM56 (Tr56-1) and found that the amount of
TRIM56 mRNA was considerably reduced in Tr56-1-nucleo-
fected cells compared with control siRNA-nucleofected cells
(Figure 2G, top). TRIM56 knockdown abrogated IFNB1 and
IL-6 mRNA induction by poly (dA:dT) (Figure 2G, top) and
CXCL10 and CCL5 (RANTES) induction after infection with
Newcastle disease virus (NDV) that stimulates the RIG-I pathway
(Figure 2G, bottom). We then examined an involvement of
TRIM56 in poly (dA:dT)- and poly (I:C)-induced IFN-b promoter
activation by a reporter assay. In TRIM56 knocked down cells,
poly (dA:dT) and poly (I:C) stimulation failed to enhance IFN-b
promoter activity (Figure 2H). Thus, TRIM56 is required for poly
(dA:dT)- and poly (I:C)-mediated type I IFN induction in human
primary cells.
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Figure 1. Identification of TRIM56
(A) HEK293 cells were transiently transfected with a plasmid derived from a mouse carcinoma cDNA library along with a reporter plasmid carrying the IFN-b
promoter (IFN-b-Luc). After stimulation with poly (I:C) or poly (dA:dT) by transfection, the cells were analyzed for IFN-b promoter activity by a reporter gene assay.
Asterisk: contained an open reading frame for TRIM56.
(B) Schematic representation of mouse TRIM56. CC; coiled-coil.
(C) Total RNA prepared from HEK293 cells stimulated with poly (I:C) or poly (dA:dT) for the indicated times was subjected to RT-PCR analysis for the expressions
of TRIM56, IFNB1, and GAPDH.
(D) MEF cells transfected with control or TRIM56 expression plasmid along with the IFN-b-Luc reporter plasmid were left unstimulated or stimulated with poly
(dA:dT) or poly (I:C) for 12 hr, and analyzed for IFN-b promoter activity by a reporter gene assay. Data represent means ± SD (n = 3).
(E) TBK1-deficient MEF cells infected with TBK1 and TRIM56 retrovirues were stimulated with poly (dA:dT) for 24 hr and analyzed for IP-10 production by ELISA.
Data represent means ± SD (n = 3). N.D., not detected.
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TRIM56 Positively Regulates STING FunctionTRIM56 Is Localized to the Cytoplasm and Does Not
Interact with Poly (dA:dT)
To determine the cellular localization of TRIM56, we expressed
RFP-TRIM56 in HeLa cells via a retrovirus system. We found
that RFP-TRIM56 was localized to the cytoplasm in the unstimu-
lated condition (Figure 3A). In response to poly (dA:dT) and
DMXAA stimulation, RFP-TRIM56 displayed a punctate pattern
in the cytoplasm (Figure 3A). We found that TRIM56 was not
localized at the ER, endosome, peroxisome, or mitochondria inIunstimulated and poly (dA:dT)-stimulated cells (Figures S2A–
S2D).
The findings that TRIM56 is an IFN-inducible gene and con-
trols the poly (dA:dT)-mediated pathway suggest that TRIM56
may serve as an intracellular sensor for dsDNA. We therefore
examined whether or not TRIM56 colocalizes with poly (dA:dT).
We coexpressed RFP-TRIM56 along with FITC-labeled poly
(dA:dT) into HeLa cells and examined their localization. There
was no colocalization between RFP-TRIM56 and FITC-labeledmmunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc. 767
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Figure 2. Requirement of TRIM56 for dsDNA
and Poly (I:C)-Induced Responses
(A) HEK293 cells treated with a control siRNA or
siRNAs targeting TRIM56 (Tr56-1 and Tr56-2)
were stimulated with poly (dA:dT) for 12 hr. The
cells were analyzed by RT-PCR for their expres-
sions of TRIM56 and GAPDH (top). Whole-cell
lysates prepared from HEK293 cells treated with
the indicated siRNAs were immunoprecipitated
(IP) and immunoblotted (IB) with anti-TRIM56
(bottom).
(B and C) HEK293 cells treated with the indicated
siRNAs were transfected with IFN-b-Luc or ISRE-
Luc plasmids. Luciferase expressionwas analyzed
after stimulation with poly (dA:dT) (B) or poly (I:C)
(C). *p < 0.001, **p < 0.002, ***p < 0.01. Data repre-
sent means ± SD (n = 3).
(D) HEK293 cells treated with the indicated siRNAs
were stimulated with poly (dA:dT) for 12 hr. Total
RNA was prepared and analyzed for the expres-
sions of IFNB1, CXCL10, andGAPDH by RT-PCR.
(E) HeLa cells treated with the indicated siRNAs
were infected with L. monocytogenes (LM) at a
MOI of 10 for 12 hr. Thereafter, total RNA was
prepared and analyzed for the expressions of
TRIM56, CXCL10, and GAPDH by RT-PCR.
(F) HEK293 cells treated with the indicated siRNAs
were stimulated with poly (dA:dT) for the indicated
periods. Nuclear extracts were prepared and
analyzed by immunoblotting via anti-IRF3.
(G) Normal human lung fibroblasts nucleofected
with control siRNA or siRNA targeting to TRIM56
(Tr56-1) were stimulated with poly (dA:dT) for 4 hr
(top) or infected with NDV (moi = 5) for 8 hr
(bottom). Total RNA was prepared and analyzed
for the expressions of the indicated genes by
RT-PCR.
(H) Normal human lung fibroblasts were nucleo-
fected with control siRNA or siRNA targeting to
TRIM56 (Tr56-1) along with IFN-b-Luc plasmid.
Luciferase expression was analyzed after stimula-
tion with poly (dA:dT) or poly (I:C). *p < 0.001, **p <
0.02. Data represent means ± SD (n = 3).
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TRIM56 Positively Regulates STING Functionpoly (dA:dT) in HeLa cells (Figure 3B). We next tested interaction
between TRIM56 and poly (dA:dT). To this end, we precipitated
cell lysates prepared from HEK293 cells overexpressing FLAG-
human TRIM56, FLAG-mouse TRIM56, FLAG-p202, or FLAG-
IPS-1 with biotin-conjugated poly (dA:dT) plus streptavidin
agarose, and blotted with FLAG antibody. FLAG-p202 was
used as a positive control because p202 (also known as
IFI202b) was identified to bind to dsDNA (Roberts et al., 2009).
We found that both human andmouse TRIM56 did not associate
with poly (dA:dT) (Figure 3C). Collectively, these findings suggest
that TRIM56 is unlikely to be a DNA sensor.768 Immunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc.TRIM56 Interacts with STING
and Accelerates IFN-b Induction
Next, we addressed the issue of whether
TRIM56 is involved in STING- and IPS-1-
mediated IFN-b induction. IFN-bpromoter
activation induced by STING and IPS-1
overexpression was significantly reduced
in TRIM56 knockdown cells (Figure 4A).In contrast, IFN-b promoter activation induced by IRF3 overex-
pressionwas unimpaired in TRIM56 knockdown cells (Figure 4A),
suggesting that TRIM56 is required for the function of STING and
IPS-1. IFN-b promoter activation induced by STING overexpres-
sion was increased by coexpression of TRIM56 but not TRIM29
(Figure 4B). Furthermore, IPS-1-mediated IFN-b promoter acti-
vationwasalso increasedbyTRIM56overexpression (Figure 4B).
In contrast, TRIM56 did not enhance TRIF-mediated IFN-b
promoter activation (Figure 4B).
We further evaluated the interaction between TRIM56 and
STING by coimmunoprecipitation assays. FLAG-STING was
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Figure 3. Cellular Localization of TRIM56
(A) HEK293 cells stably expressing RFP-TRIM56 were stimulated with poly (dA:dT) or DMXAA for 12 hr. The cells were fixed and observed by fluorescence
microscopy.
(B) HeLa cells stably expressing RFP-TRIM56 were transfected with FITC-labeled poly (dA:dT). At 8 hr after transfection, cells were fixed and observed by fluo-
rescence microscope.
(C) HEK293 cells were transfected with control (lane 1), FLAG-p202 (lane 2), FLAG-mouse TRIM56 (lane 3), FLAG-human TRIM56 (lane 4), or FLAG-human IPS-1
(lane 5). Cell lysates were incubatedwith streptavidin beads with or without biotinylated poly (dA:dT) (left) or anti-FLAG beads (right) for 4 hr. Bounded protein was
analyzed by immunoblot with anti-FLAG. Asterisk: p202 band.
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TRIM56 Positively Regulates STING Functioncoprecipitated with TRIM56 antibody but not with two control
antibodies (Figure 4C), indicating that endogenous TRIM56
forms a complex with FLAG-STING. We then searched for the
region of TRIM56 that was responsible for the interaction with
STING by constructing several deletion mutants and found that
the STING C-terminal region was coprecipitated with Myc-
TRIM56 FL (encoding full-length TRIM56), Myc-TRIM56 DR
(lacking the RING finger domain), and Myc-TRIM56 DN (lacking
the RING-finger and B-box domains) but not with Myc-TRIM56
DC (encoding the N-terminal RING-finger and B-box domains)
(Figure 4D), indicating that the C-terminal region of TRIM56 is
necessary for the interaction with the C-terminal region of
STING. Unlike STING, we were unable to detect an interaction
between TRIM56 and IPS-1 (data not shown).
STING was previously shown to display punctate structures in
response to poly (dA:dT) stimulation. This finding prompted us toIinvestigate whether TRIM56 colocalizes with STING. To this end,
we coexpressed GFP-STING and RFP-TRIM56 and determined
their cellular localizations after poly (dA:dT) stimulation. GFP-
STING displayed punctate structures, and several dots were
merged with those of RFP-TRIM56 (Figure S3A). It was reported
that STING becomes relocalized from the ER to perinuclear vesi-
cles containing exocyst components (Ishikawa et al., 2009; Sai-
toh et al., 2009). However, colocalization between TRIM56 and
exocyst complex component 2 (EXOC2) (also known as SEC5)
was not observed (Figure S3B). These findings suggest that
TRIM56 is localized with STING after poly (dA:dT) stimulation
and rapidly removed before STING relocalizes to exocyst.
Induction of STING Ubiquitination by TRIM56
In HEK293 cells transiently transfected with FLAG-STING,
immnoblotting with anti-FLAG showed two bands with sizes ofmmunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc. 769
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Figure 4. TRIM56 Interacts with STING and
Enhances IFN-b Promoter Activation
(A) HEK293 cells treated with the indicated siRNAs
were transfected with control, FLAG-STING,
FLAG-IPS-1, or FLAG-IRF3 expression plasmids
along with an IFN-b-Luc reporter plasmid, and
analyzed for IFN-b promoter activity by a reporter
gene assay. Data represent means ± SD (n = 3).
*p < 0.01, **p < 0.002.
(B) HEK293 cells were cotransfected with the indi-
cated combinations of expression plasmids en-
coding STING (100 ng), IPS-1 (1 ng), TRIF (1 ng),
TRIM56 (100 or 250 ng), or TRIM29 (100 or
250 ng) along with an IFN-b-Luc reporter plasmid
and subjected to a reporter assay. Data represent
means ± SD (n = 3).
(C) Cell lysates prepared from HEK293 cells trans-
fectedwithFLAG-STINGwere immunoprecipitated
with the indicated antibodies and immunoblotted
with anti-FLAG (top). Whole cell lysates (WCL)
were immunoblotted with anti-FLAG (bottom).
(D) Cell lysates prepared from HEK293 cells
cotransfected with the indicated combinations of
expression plasmids were immunoprecipitated
and immunoblotted with the indicated antibodies.
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TRIM56 Positively Regulates STING Functionapproximately 40 and 80 kDa. The 80 kDa band disappeared
when anti-FLAG immunoprecipitates were treated with 8M
urea, indicating that the 80 kDa band corresponds to a STING
dimer, which was consistent with a previous report (Figure S4A;
Sun et al., 2009). Notably, the 80 kDa band was increased by
poly (dA:dT) stimulation and slightly increased by poly (I:C) stim-
ulation (Figure 5A). Moreover, the anti-FLAG detected smeared
bands over the 80 kDa band region in the poly (dA:dT)-stimulated
cells (Figure 5A). These results suggest that poly (dA:dT) stimu-
lation induces STING dimerization as well as modifications
such as ubiquitination. Immunoblot analysis with ubiquitin anti-
body indicated that poly (dA:dT) stimulation increased the ubiq-770 Immunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc.c
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p
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T
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buitination of anti-FLAG-STING immuno-
precipitates, which was impaired by
TRIM56 knockdown (Figure 5B, top).
Furthermore, TRIM56 knockdown abro-
gated poly (dA:dT)-induced smeared
bands over the 80 kDa band region as de-
tected by anti-FLAG (Figure 5B, bottom).
These results suggest that poly (dA:dT)
stimulation triggered ubiquitination of
STING or STING-associated proteins in
a manner dependent on TRIM56.
We overexpressed FLAG-STING along
with or without Myc-TRIM56, and STING
ubiquitination was examined by immuno-
blot analysis via ubiquitin antibody. Ubiq-
uitination of FLAG-STING was induced in
cells expressing TRIM56 (Figure 5C, top).
Moreover, an amount of the 80 kDa band
corresponding to the dimer of FLAG-
STING in TRIM56-expressing cells was
increased compared with that in control
cells (Figure 5C, middle).
Immunoblot analysis via ubiquitin lysine (K) 63 antibody indi-
ated that TRIM56 overexpression increased the STING ubiqui-
nation linked to K63 (Figure 5D). By contrast, TRIM56 overex-
ression did not affect the K48-linked ubiquitination of STING
s determined by immunoblot analysis via ubiquitin K48 anti-
ody (data not shown). These results suggest that TRIM56 pref-
rentially catalyzes K63-linked ubiquitination of STING.
We denatured anti-FLAG immunoprecipitates of cell lysates
repared from cells transfected with FLAG-STING and Myc-
RIM56 by boiling in a buffer containing 1%SDS, followed by re-
munoprecipitated with anti-FLAG and analyzed by immuno-
lotting with antiubiquitin. In this condition, ubiquitination was
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Figure 5. Ubiquitination of STING by
TRIM56
(A) HEK293 cells transfected with FLAG-STING
were stimulated with poly (I:C) or poly (dA:dT) for
12 hr. Cell lysates were immunoprecipitated and
immunoblotted with anti-FLAG.
(B) HEK293 cells treated with siRNA for control
(lane 1, 2) or TRIM56 (lane 3, 4) were stimulated
with poly (dA:dT) for 12 hr. Cell lysates were immu-
noprecipitated with anti-FLAG and blotted with
anti-ubiquitin (top) or -FLAG (bottom).
(C) HEK293 cells were transfected with FLAG-
STING and Myc-TRIM56 as indicated. Cell lysates
were immunoprecipitated with anti-FLAG or anti-
Myc and immunoblotted with anti-ubiquitin, anti-
FLAG, or anti-Myc as indicated.
(D) Cell lysates prepared in (C) were immunopre-
cipitated with anti-FLAG and blotted with anti-
ubiquitin K63. Single asterisk: high molecular
weight bands; double asterisk: 80 kDa band corre-
sponding to the STING dimer.
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tin chains are covalently attached to STING. It was recently
demonstrated that RIG-I binds to unanchored K63-linked polyu-
biquitin chains that are likely to be synthesized by TRIM25, acti-
vating downstream signaling (Zeng et al., 2010). This suggests
the possibility that in addition to covalent attachment of ubiqui-
tin, STING is also associated with unanchored ubiquitin chains.
In this regard, we lysed cells transfected with FLAG-STING
and Myc-TRIM56 in the regular lysis buffer that did not con-
tain SDS, treated anti-FLAG immunoprecipitates with Isopepti-
dase T (Iso T; also known as USP5) that removes unanchored
ubiquitin chains, and blotted with anti-ubiquitin. Iso T treatment
decreased the amount of ubiquitination (Figure S4C), suggesting
that STING is associated with unanchored ubiquitin chains or
their associated proteins such as RIG-I under nondenatured
condition.Immunity 33, 765–776, NRole of STING Lysine 150
in the Responses to dsDNA
To determine the lysine residue(s) in
STING that are critical for TRIM56-
mediated ubiquitination, we constructed
a series of FLAG-STING mutants in
which individual lysine residues were
substituted with an arginine residue
(K20R, K137R, and K150R). HA-ubiquitin
and Myc-TRIM56 were coexpressed
with FLAG-STING or STING mutants in
HEK293 cells, and anti-FLAG immuno-
precipitates were immunoblotted with
HA antibody. The amount of ubiquitina-
tion was unaffected by mutation of lysine
20 or 137, but was severely abrogated
by mutation of lysine 150 (Figure 6A).
Notably, immunoblot analysis with anti-
FLAG demonstrated that STING K150R
failed to form a dimer (Figure 6A). More-
over, poly (dA:dT) stimulation resulted
in increased dimer formation as well asubiquitination of STING, and these increases were abrogated
by mutation of lysine 150 (Figure 6B). We next performed coim-
munoprecipitation assay to examinewhether STING lysine 150 is
required for the dimer formation. When FLAG-STING and Myc-
STING were expressed together in HEK293 cells, FLAG-STING
was coprecipitated with Myc antibody, indicating that FLAG-
STING interacts with Myc-STING. In contrast, interaction
between FLAG-STING K150R and Myc-STING K150R was
reduced (Figure 6C). Furthermore, poly (dA:dT) stimulation failed
to induce the interaction between FLAG-STINGK150R andMyc-
STING K150R (data not shown). These results strongly suggest
that STING lysine 150 is the major acceptor site for the
TRIM56-mediated K63-linked ubiquitin chains and that this
lysine residue is required for the dimer formation.
Next, we addressed whether STING ubiquitination is linked to
IFN-b induction. Overexpression of STING K150R failed toovember 24, 2010 ª2010 Elsevier Inc. 771
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Figure 6. STING Lysine 150 Is Required for
IFN-b Promoter Activation
(A) HEK293 cells were transfected with FLAG-
STING WT, K20R, K137R, or K150R along with
Myc-TRIM56 and HA-ubiquitin. Cell lysates were
immunoprecipitated with anti-FLAG or anti-Myc
and immunoblotted with anti-FLAG, anti-Myc, or
anti-HA.
(B) HEK293 cells transfected with FLAG-STING
WT or FLAG-STING K150R were stimulated with
poly (dA:dT). Cell lysates were immunoprecipi-
tated with FLAG antibody and immunoblotted
with anti-FLAG (top) or anti-ubiquitin (bottom).
Asterisk: 80 kDa band corresponding to the STING
dimer (A, B).
(C) Cell lysates prepared from HEK293 cells
cotransfected with the indicated combinations of
expression plasmids were immunoprecipitated
and immunoblotted with the indicated antibodies.
(D) HEK293 cells transfected with increasing
amounts of control, STING WT, STING K20R,
STING K137R, or STING K150R plasmids (1, 10,
100, or 250 ng) along with an IFN-b-Luc reporter
plasmid were analyzed by a reporter assay (left).
Cell lysates were immunoblotted with anti-FLAG
(right).
(E) HEK293 cells transfected with the indicated
combinations of plasmids for STING, STING
K150R, and TRIM56 along with the IFN-b-Luc
reporter plasmid were analyzed by a reporter
gene assay.
(F) HEK293 cells transfected with the indicated
amounts of control or FLAG-STING K150R plas-
mids along with the IFN-b-Luc reporter plasmid
were stimulated with poly (dA:dT) and analyzed
by a reporter gene assay. Data represent means
± SD (n = 3).
*p < 0.04, **p < 0.01, ***p < 0.001.
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by STING, STING K20R, and STING K137R were comparable
(Figure 6D). Moreover, STING K150R remained unable to
enhance IFN-b promoter activation even when coexpressed
with TRIM56 (Figure 6E), and it acted as a dominant-negative
form for suppression of the poly (dA:dT)-triggered IFN-b pro-
moter activation (Figure 6F). Collectively, these findings indicate
that TRIM56 catalyzes ubiquitination of STING lysine 150 during
poly (dA:dT)-triggered signaling, which is important for the
induction of IFN-b.
STING Ubiquitination Is Required for Recruitment
of TBK1
It was shown that STING forms a complex with TBK1 and acti-
vates IRF3 (Ishikawa and Barber, 2008; Zhong et al., 2008).772 Immunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc.S
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Figure 7. STING Ubiquitination Is Required
for Recruitment of TBK1
(A) HEK293 cells were transfected with the indi-
cated combinations of plasmids for FLAG-STING,
FLAG-TRIM56, and Myc-TBK1. Cell lysates were
immunoprecipitated and immunoblotted with the
indicated antibodies.
(B) HEK293 cells transfected with the indicated
combinations of plasmids for STING, and TRIM56
DN along with the IFN-b-Luc reporter plasmid
were analyzed by a reporter gene assay. Data
represent means ± SD (n = 3).
(C) HEK293 cells were transfected with the indi-
cated combinations of plasmids for FLAG-STING
WT, FLAG-TRIM56 DN, and Myc-TBK1. Cell
lysates were immunoprecipitated and immuno-
blotted with the indicated antibodies.
(D) HEK293 cells were transfected with the indi-
cated combinations of plasmids for FLAG-STING
WT, FLAG-STING K150R, and Myc-TBK1. Cell
lysates were immunoprecipitated and immuno-
blotted with the indicated antibodies.
Single asterisk: high molecular weight bands (A);
double asterisk: phosphorylated STING (A, C, D).
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TRIM56 Positively Regulates STING FunctionandSTING. Coprecipitation of FLAG-STINGwithMyc-TBK1was
disrupted by TRIM56 DN overexpression (Figure 7C). Moreover,
TBK1-mediated STING phosphorylation was not observed in
the presence of TRIM56 DN (Figure 7C). Thus, TRIM56 DN
disrupts STING and TBK1 interaction probably through inhibiting
STING ubiquitination.
Next, we investigated whether STING ubiquitination is
required for TBK1 activation. We overexpressed Myc-TBK1
together with FLAG-STING or FLAG-STING K150R and exam-
ined their interactions. FLAG-STING was coprecipitated with
TBK1 whereas FLAG-STING K150R was not (Figure 7D). More-
over, FLAG-STING, but not FLAG-STING K150R, migrated
slowly in the presence of Myc-TBK1 (Figure 7D). These findings
suggest that STING ubiquitination is a prerequisite for TBK1
recruitment and activation.
Previously, it was demonstrated that STING relocalizes to
intracellular punctate structures along with TBK1 after poly
(dA:dT) stimulation (Ishikawa et al., 2009; Saitoh et al., 2009).
We therefore examined whether STING ubiquitination is prereq-
uisite of STING translocation. We reconstituted GFP-TBK1 into
TBK null MEFs by retrovirus infection. We further transduced
RFP-STING WT or K150R into these cells and determined their
localizations. STING WT was translocated to perinuclear vesi-
cles from the cytoplasm in response to poly (dA:dT), where
TBK1 was colocalized (Figure S5B). Similarly, STING K150R
was also translocated to the perinuclear vesicles and merged
with TBK1 (Figure S5B). These findings suggest that STING
translocation does not require ubiquitination.Immunity 33, 765–776, NTaken together, these findings sug-
gest that poly (dA:dT) stimulation
induces TRIM56 expression, which pro-
motes STING ubiquitination. Ubiquiti-
nated STING in turn forms a dimer or
oligomer to recruit TBK1, which is impor-tant for its kinase activation as well as subsequent type I IFN
induction.
DISCUSSION
More than 60 TRIM proteins have been identified in humans and
mice (Carthagena et al., 2009; Nisole et al., 2005; Ozato et al.,
2008). They contain an N-terminal RBCC motif composed of
a RING domain, one or two B-boxes, and a coiled-coil domain
and have C-terminal regions with different structures. The
members of this family are largely classified to 10 subfamilies
based on their C-terminal domains (Ozato et al., 2008; Short
and Cox, 2006). Notably, some of them are induced by stimula-
tion with type I and II IFNs and are involved in antiviral innate
immune responses through ubiquitination. TRIM25 promotes
K63-linked ubiquitination of RIG-I to activate antiviral innate
immune responses (Gack et al., 2007). TRIM21 (also known as
Ro52 and SSA1), which is found in sera from patients with
systemic lupus erythematosus and Sjo¨gren’s syndrome, influ-
ences activation of IRF family proteins via K48- or K63-linked
ubiquitination (Higgs et al., 2008; Kong et al., 2007; Yang et al.,
2009). In contrast, TRIM30a binds TAK1 protein kinase and
induces degradation of the TAK1-binding proteins TAB2 and
TAB3 to suppress TLR-mediated NF-kB activation (Shi et al.,
2008). Therefore, TRIM family proteins may represent new
components that regulate innate immune responses via ubiqui-
tination. In the present study, we showed that TRIM56 regulates
dsDNA-driven innate immune responses. TRIM56 interactedovember 24, 2010 ª2010 Elsevier Inc. 773
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linked polyubiquitin chains are covalently attached to STING,
and this modification is critical for STING dimerization or oligo-
merization as well as IFN-b induction. In addition, it is also likely
that STING is noncovalently associated with unanchored polyu-
biquitin chains that are removed by Iso T. It was recently
reported that unanchored K63-polyubiquitin chains associate
with RIG-I and activate downstream signaling (Zeng et al.,
2010). Moreover, STING deficiency or STING knockdown abro-
gates the antiviral responses to certain RNA viruses that are
recognized by RIG-I (Ishikawa et al., 2009), indicating that STING
is involved in RIG-I signaling. Therefore, unanchored polyubiqui-
tin chains may function as a platform that assembles a signaling
complex involving RIG-I and STING. Collectively, it is speculated
that STING is regulated by two different types of K63-linked
ubiquitination. STING is initially attached with ubiquitin by
TRIM56 to form a dimer or oligomer, which is then recruited to
unanchored polyubiquitin chains along with RIG-I or an unknown
DNA sensor for induction of antiviral innate immune responses.
We found that TRIM56 overexpression enhanced poly (I:C)-
and IPS-1-induced IFN-b promoter activation and that TRIM56
knockdown abrogated this activation as well as NDV-induced
cytokine gene expression, suggesting that TRIM56 is involved
in RLR signaling pathways. However, we were unable to detect
an interaction between TRIM56 and IPS-1 by coimmunoprecipi-
tation assays (data not shown), and the TRIM56 signals were not
merged with the signals for a mitochondrial marker where IPS-1
is localized. In addition, modifications of IPS-1 such as ubiquiti-
nation or phosphorylation were not induced when TRIM56
was overexpressed (data not shown). Therefore, the ability of
TRIM56 to enhance IPS-1 function may be based on TRIM56-
mediated modulation of the endogenous STING function.
Recently, the phosphatase Eyes absent 4 (EYA4) was identified
to enhance innate immune responses to dsDNA andRNA viruses
(Okabe et al., 2009). EYA4 was shown to bind to both IPS-1 and
STING. Therefore it is possible that EYA4 may be involved in
TRIM56-mediated IPS-1 activation.
TBK1 is an essential protein kinase that phosphorylates IRF3
and induces type I IFN in dsDNA-stimulated cells (Ishii et al.,
2008). TBK1 is localized in the cytoplasm in a different manner
to STING but translocates to the punctate structures, where
STING is colocalized, in response to dsDNA stimulation. This
translocation is abrogated by STING deficiency (Ishikawa
et al., 2009), indicating that translocation of TBK1 to STING-con-
taining vesicles is required for IRF3 activation. These findings,
together with our finding that STING K150R did not interact
with TBK1, suggest that TBK1 is recruited to the punctate struc-
tures when STING is ubiquitinated by TRIM56. However, it is
noteworthy that similar to STING WT, STING K150R also trans-
locates to the perinuclear vesicles in response to poly (dA:dT)
stimulation, where it colocalizes with TBK1. This observa-
tion suggests that TRIM56-mediated STING ubiquitination is
dispensable for dsDNA-mediated translocation of STING to the
punctate structures; rather this modification is required for phys-
ical interaction with TBK1within the structure, which is important
in IRF3 activation. We recently demonstrated that the autoph-
agy-related protein Atg9a protects against aberrant dsDNA-trig-
gered responses by preventing the dynamic translocation of
STING to these punctate structures (Saitoh et al., 2009). There-774 Immunity 33, 765–776, November 24, 2010 ª2010 Elsevier Inc.fore, it is possible that dsDNA-driven STING translocation may
be regulated by Atg9a or its related proteins but not TRIM56.
It was demonstrated that exocyst components are involved in
these punctate structures along with STING and TBK1 and that
the exocyst components play a role in TBK1 activation (Ishikawa
et al., 2009). However, colocalization between TRIM56 and
EXOC2 was not observed in the present study. This finding
suggests that TRIM56 is removed from the STING-containing
vesicles after it causes STING ubiquitination. Alternatively,
TRIM56 may be rapidly degraded within EXOC2-containing
vesicles.
RNF5 interacts with STING and mediates K48-linked ubiquiti-
nation to induce degradation, thereby suppressing antiviral
innate immune responses (Zhong et al., 2009). RNF5 is localized
to the ER andmitochondria, and interactions between RNF5 and
STING occur at the mitochondria during RNA virus infection.
Thus, RNF5 may negatively regulate RLR signaling by targeting
STING that is localized to mitochondria for degradation. These
authors identified STING lysine 150 as an essential residue for
K48-linked ubiquitination. In contrast, we found that TRIM56
preferentially promoted K63-linked ubiquitination of the same
lysine residue of STING that was important for the dimer forma-
tion and TBK1 activation. Furthermore, mitochondrial localiza-
tion of TRIM56 was not observed. Taken together, it is likely
that STING is negatively and positively regulated by different
types of ubiquitination. Specifically, TRIM56 induces STING
dimerization during dsDNA-triggered signaling to potentiate
antiviral responses while RNF5 may induce degradation of mito-
chondrial STING to suppress RLR-induced antiviral responses.
The findings that TRIM56 failed to interact with dsDNA and
that there was no colocalization between TRIM56 and dsDNA
within cells suggest that TRIM56 is unlikely to be a dsDNA
sensor, and instead facilitates the STING function by ubiquitina-
tion. Although a cytosolic dsDNA sensor responsible for type I
IFN induction still remains to be identified, this study on
TRIM56 characterization and future analyses of TRIM56-defi-
cient animal models will help toward understanding the roles
of the dsDNA sensor-driven signaling pathway in antiviral and
antibacterial immune responses as well as the pathogenesis of
autoimmune and inflammatory diseases that are caused by
pathogen or host DNA.
EXPERIMENTAL PROCEDURES
Functional Screening
HEK293 cells seeded on 24-well plates (1 3 105 cells/well) were transiently
transfected with IFN-b promoter-luciferase reporter plasmids (50 ng) and
a plasmid DNA (100 ng) prepared from mouse or human cDNA library cloned
into pCMV-SPORTS6 (Open Biosystems) via Lipofectamine 2000 (Invitrogen).
After 12 hr, the cells were left unstimulated or stimulated with poly (dA:dT)
(100 ng/ml) or poly (I:C) (1 mg/ml) by transfection. After another 24 hr, the cells
were lysed with Passive Lysis Buffer (Promega) and measured for their lucif-
erase activities via a Dual-Luciferase Reporter Assay System (Promega)
according to the manufacturer’s instructions. As an internal control, 50 ng of
a Renilla luciferase reporter gene was used simultaneously.
Cells and Reagents
HEK293, HeLa, and MEF cells were cultured in DMEM (Sigma) supplemented
with 10% FBS (GIBCO) in a 5%CO2 incubator. TBK1-deficient MEF cells were
described previously (Hemmi et al., 2004). Normal human lung fibroblastswere
obtained from Lonza. Human lung fibroblasts were maintained in Fibroblast
Immunity
TRIM56 Positively Regulates STING FunctionBasal Medium (Lonza; CC-3132) containing hFGF-B, insulin, FBS, and genta-
micin/amphotericin-B (Lonza; CC-4126) according to the manufacturer’s
instruction. Poly (dA:dT) and poly (I:C) were purchased from InvivoGen.
Biotin-conjugated poly (dA:dT), FITC-labeled poly (dA:dT) was purchased
from Invitrogen. DMXAA was obtained from Sigma. L. monocytogenes and
NDV were described previously (Kawai et al., 2005; Uematsu et al., 2007).
Streptavidin agarose resin was purchased from Thermo Scientific. TRIM56
polyclonal, TRIM56 monoclonal, STING polyclonal, and ubiquitin (FK2) mono-
clonal antibodies were purchased from Novus Biologicals, Abcam, Imgenex,
and Assay Designs, respectively. IRF3 (FL-425), c-myc (9E10), and HA
(3F10) antibodies were purchased from Santa Cruz Biotechnology Inc. Anti-
FLAG M2 Affinity Agarose Gel and anti-FLAG M2-Peroxidase antibody were
purchased from Sigma. Anti-mouse IgG-Alexa Fluor 568 was purchased
from Molecular Probes. Ub K63 monoclonal antibody was purchased from
Millipore.
Plasmids
Mouse TRIM56, TRIM56 DR (amino acids 64–734), TRIM56 DN (amino acids
209–734), and TRIM56 DC (amino acids 1–208) were amplified by PCR and
ligated into pFLAG-CMV6 or pEF-BOS to generate Flag- and Myc-tagged
expression constructs, respectively. Human TRIM56, TRIM29, STING,
STING-C (amino acids 174–379), and mouse p202 were amplified by RT-
PCR and also ligated into pFLAG-CMV6 or pEF-BOS. TRIF, IPS-1, IRF3,
TBK1 expression plasmids, and reporter plasmids were described previously
(Kawai et al., 2005). HA-tagged ubiquitin was amplified by RT-PCR and ligated
into pEF-BOS. STING K20R, STING K137R, and STING K150R were gener-
ated via a QuikChange II Site-directed Mutagenesis Kit (Stratagene). The
expression plasmids pMRX-GFP-ires-puro and pMRX-RFP-ires-puro were
described previously (Saitoh et al., 2009). The cDNA fragments encoding
TRIM56 and TBK1 were amplified by RT-PCR and inserted into pMRX-RFP-
ires-puro and pMRX-GFP-ires-puro, respectively. Packaging cell line Platinum
E cells (Cell Biolabs Inc.) plated on 60 mm dishes (1 3 106 cells/dish) were
transfected with 4 mg of retroviral expression plasmid together with 1 mg of
pVSV-G plasmid via Lipofectamine 2000. At 48 hr after transfection, the
viruses were harvested, mixed with Polybrene (Sigma), and infected into
HeLa or MEF cells. The infected cells were selected in the presence of 3 mg/ml
puromycin for 5–7 days.
Reporter Assay
HEK293 or MEF cells plated on 24-well plates (1 3 105 cells/well) were tran-
siently transfected with 50 ng of luciferase reporter plasmid together with
a total of 1.0 mg of expression plasmid or empty control plasmid with Lipofect-
amine 2000 or FuGENE 6 (Roche), respectively. Human lung fibroblasts plated
on 24-well plates (5 3 104 cells/well) were electroporated with 100 ng of lucif-
erase reporter plasmid with Amaxa Nucleofector (Amaxa Biosystems) accord-
ing to the manufacturer’s instructions. At 24 hr after the transfection, the cells
were stimulated and luciferase activities in the total cell lysates weremeasured
with a Dual-Luciferase Reporter Assay System (Promega). A Renilla luciferase
reporter plasmid (50 ng) was used as an internal control.
RT-PCR
Total RNA was isolated with Trizol reagent (Invitrogen) and reverse transcribed
with ReverTra Ace (Toyobo) according to themanufacturer’s instructions. PCR
was performed with the following primers: IFNB1, 50-CAGCAATTTTCAGTGTC
AGAAGCT-30 and 50-TCATCCTGTCCTTGAGGCAGTAT-30; CXCL10, 50-ATG
AATCAAACTGCGATTCCTGATTTGCTGC-30 and 50-TTAAGGAGATCTTTTA
GCCATTTCCTTGC-30; IL-6, 50-GTAGCCGCCCCACACAGACAGCC-30 and
50-GCCATCTTTGGAAGGTTC-30; CCL5, 50-ACCAGTGGCAAGTGCTCCA-30
and 50-TCCGAACCCATTTCTTCTCT3-0; and GAPDH, 50-ACCACCATGGAG
AAGGCTGG-30 and 50-CTGAGTGTAGCCCAGGATGC-30.
Immunoprecipitation and Immunoblot Analysis
HEK293 cells seeded on 100 mm dishes were transiently transfected with
a total of 10 mg of various plasmids. At 24 hr after the transfection, the cells
were lysed in lysis buffer (1% Nonidet P-40, 50 mM Tris-HCl [pH 7.4],
150mMNaCl) supplemented with a complete protease inhibitor cocktail tablet
(Roche). For immunoblot with ubiquitin antibody, RIPA buffer (1% Nonidet
P-40, 25 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% SDS) was used. ExtractionIof nuclear proteins, immunoprecipitation, and immunoblot were carried out as
described previously (Kawai et al., 2005).
RNA Interference
Double-stranded RNA duplexes corresponding to human TRIM56 mRNA
were purchased from Invitrogen. The targeting sequences were as follows:
TRIM56-1 sense, 50-GAGCAGCGACUUCCUGGCCUGUAAA-30; TRIM56-2
sense, 50-CCACGUGGAGGUGUACAAUAUGGAA-30. Negative control oligo
was purchased from Invitrogen. HEK293 and HeLa cells were transfected
with 50 nM siRNA via Lipofectamine RNAi MAX (Invitrogen) according to the
manufacturer’s instructions. Human lung fibroblasts were electroporated
with 100 nM siRNA via Amaxa Nucleofector (Amaxa Biosystems) according
to the manufacturer’s instructions. At 48 hr after transfection, the cells were
used for further experiments. Knockdown of TRIM56 mRNA was verified by
RT-PCR with the primers 50-GTGGAGGCTGCCGAAGAAGC-30 and 50-GATT
ACCACACTATTCTGCTG-30.
Fluorescence Microscopy
Cells cultured on coverslips were fixed with 3% paraformaldehyde in phos-
phate-buffered saline for 12 min, mounted with Prolong Gold antifade reagent
(Invitrogen), and examined with an Olympus IX81 microscope.
Statistical Analysis
Differences were analyzed for statistical significance with Student’s t test.
A p value of less than 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
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